Medtronic balance sheet
At the end of fiscal 2026, Medtronic had total assets of $93.03bn, total liabilities of $42.96bn and shareholders' equity of $49.46bn. It held $1.95bn in cash against $28.13bn of debt.
Balance sheet
| Fiscal year | 2013Apr 2013 | 2014Apr 2014 | 2015Apr 2015 | 2016Apr 2016 | 2017Apr 2017 | 2018Apr 2018 | 2019Apr 2019 | 2020Apr 2020 | 2021Apr 2021 | 2022Apr 2022 | 2023Apr 2023 | 2024Apr 2024 | 2025Apr 2025 | 2026Apr 2026 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.9 | 1.4 | 4.8 | 2.9 | 5.0 | 3.7 | 4.4 | 4.1 | 3.6 | 3.7 | 1.5 | 1.3 | 2.2 | 1.9 | 1.7 |
| Receivables | — | 3.8 | 5.1 | 5.6 | 5.6 | 6.0 | 6.2 | 4.6 | 5.5 | 5.6 | 6.0 | 6.1 | 6.5 | 6.6 | 6.4 |
| Inventory | — | 1.7 | 3.5 | 3.5 | 3.3 | 3.6 | 3.8 | 4.2 | 4.3 | 4.6 | 5.3 | 5.2 | 5.5 | 6.0 | 6.2 |
| Total current assets | — | 21.2 | 30.8 | 23.6 | 24.9 | 23.0 | 22.0 | 22.0 | 22.5 | 23.1 | 21.7 | 21.9 | 23.8 | 24.8 | 24.4 |
| Goodwill | 10.3 | 10.6 | 40.5 | 41.5 | 38.5 | 39.5 | 40.0 | 39.8 | 42.0 | 40.5 | 41.4 | 41.0 | 41.7 | 42.6 | 43.2 |
| Total assets | — | 37.9 | 106.7 | 99.6 | 99.9 | 91.4 | 89.7 | 90.7 | 93.1 | 91.0 | 90.9 | 90.0 | 91.7 | 93.0 | 93.3 |
| Accounts payable | — | 0.7 | 1.6 | 1.7 | 1.6 | 1.6 | 2.0 | 2.0 | 2.1 | 2.3 | 2.7 | 2.4 | 2.4 | 2.6 | 2.7 |
| Total current liabilities | — | 5.6 | 9.2 | 7.2 | 14.3 | 10.1 | 8.5 | 10.4 | 8.5 | 12.4 | 9.1 | 10.8 | 12.9 | 11.7 | 11.8 |
| Short-term debt | — | 1.6 | 2.4 | 1.0 | 7.5 | 2.1 | 0.8 | 2.8 | 0.0 | 3.7 | 0.0 | 1.1 | 2.9 | 1.8 | 2.5 |
| Long-term debt | — | 10.3 | 33.2 | 29.9 | 25.9 | 23.7 | 24.6 | 22.1 | 26.4 | 20.4 | 24.3 | 23.9 | 25.6 | 26.2 | 25.6 |
| Total debt | 0.0 | 11.9 | 36.2 | 31.1 | 33.4 | 25.8 | 25.4 | 24.9 | 26.6 | 24.3 | 24.6 | 25.2 | 28.7 | 28.1 | 28.2 |
| Total liabilities | — | 18.5 | 53.5 | 47.6 | 49.5 | 40.6 | 39.5 | 39.8 | 41.5 | 38.3 | 39.3 | 39.6 | 43.4 | 43.0 | 42.5 |
| Shareholders' equity | 18.7 | 19.4 | 53.2 | 52.1 | 50.2 | 50.7 | 50.1 | 50.7 | 51.4 | 52.6 | 51.5 | 50.2 | 48.0 | 49.5 | 50.2 |
| Shares outstanding | — | 999m | — | 1,399m | 1,369m | 1,354m | 1,341m | 1,341m | 1,345m | 1,331m | 1,331m | 1,311m | 1,282m | 1,280m | 1,280m |
| Quarter | 2025 Q2Oct 2024 | 2025 Q3Jan 2025 | 2025 Q4Apr 2025 | 2026 Q1Jul 2025 | 2026 Q2Oct 2025 | 2026 Q3Jan 2026 | 2026 Q4Apr 2026 | 2027 Q1Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 6.3 | 6.1 | 6.5 | 6.3 | 6.4 | 6.4 | 6.6 | 6.4 |
| Inventory | 5.5 | 5.6 | 5.5 | 5.9 | 6.2 | 6.3 | 6.0 | 6.2 |
| Total current assets | 22.4 | 22.5 | 23.8 | 23.2 | 24.0 | 24.1 | 24.8 | 24.4 |
| Goodwill | 41.2 | 40.8 | 41.7 | 42.0 | 41.8 | 41.9 | 42.6 | 43.2 |
| Total assets | 90.0 | 90.0 | 91.7 | 91.0 | 91.3 | 91.5 | 93.0 | 93.3 |
| Accounts payable | 2.4 | 2.3 | 2.4 | 2.6 | 2.6 | 2.6 | 2.6 | 2.7 |
| Total current liabilities | 12.2 | 11.8 | 12.9 | 11.5 | 9.9 | 9.5 | 11.7 | 11.8 |
| Short-term debt | 3.7 | 2.6 | 2.9 | 2.4 | 1.4 | 0.2 | 1.8 | 2.5 |
| Long-term debt | 24.6 | 24.0 | 25.6 | 26.2 | 27.7 | 27.9 | 26.2 | 25.6 |
| Total debt | 28.3 | 26.6 | 28.5 | 28.6 | 29.1 | 28.1 | 28.0 | 28.2 |
| Total liabilities | 41.3 | 40.4 | 43.4 | 42.8 | 42.5 | 42.3 | 43.0 | 42.5 |
| Shareholders' equity | 48.5 | 49.4 | 48.0 | 47.9 | 48.7 | 49.0 | 49.5 | 50.2 |
| Shares outstanding | 1,283m | 1,283m | 1,282m | 1,282m | 1,282m | 1,283m | 1,280m | 1,280m |
Compare with peers
- Abbott Laboratories balance sheet
- Stryker Corporation balance sheet
- GE HealthCare balance sheet
- Boston Scientific balance sheet
- Koninklijke Philips NV balance sheet
Head to head: ABT vs MDTMDT vs SYKGEHC vs MDT
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies